InflaRx N.V. Profit Margin

The latest profit margin for IFRX is 332494.35% as of June 2026. That compares with -27815.69% in the prior-year period — up 1295.3% year over year. That is above the Healthcare sector average of 21.34%. Investors often review this figure alongside InflaRx N.V.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, IFRX's profit margin moved from -27815.69% to 332494.35% — a 1295.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in InflaRx N.V.'s valuation or profitability profile.

Against Healthcare companies, IFRX currently prints 332494.35% for profit margin, while the sector average sits near 21.34%. That is roughly 1558330.5% above the sector mean. Large gaps often invite a closer look at InflaRx N.V.'s growth, margins, and balance sheet.

Profit Margin shows how effectively InflaRx N.V. converts resources into returns. At 332494.35%, IFRX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -27815.69% in the prior-year period — up 1295.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IFRX's profit margin (332494.35%), review year-over-year change from -27815.69%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.